Nonsteroidal anti-inflammatory agents in neonates

Pediatric Drugs

Volumn 5, Issue 6, 2003, Pages 385-405

  Morris, John L ^a   Rosen, David A ^a   Rosen, Kathleen R ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DOPAMINE; ENALAPRIL; FUROSEMIDE; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; MEFENAMIC ACID; MORPHINE DERIVATIVE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE AGONIST; PARACETAMOL; PROSTAGLANDIN; ROFECOXIB; SULINDAC;

AMNION FLUID LEVEL; ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; BLEEDING; BRAIN BLOOD FLOW; BRAIN DEVELOPMENT; BRAIN HEMORRHAGE; BRAIN HYPOXIA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG FORMULATION; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG OVERDOSE; DRUG SAFETY; DRUG USE; EDEMA; FETUS HYDROPS; FEVER; GASTROINTESTINAL SYMPTOM; HEART INFARCTION; HEMOSTASIS; HUMAN; INTESTINE PREPARATION; INTOXICATION; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY MALFORMATION; LIVER TOXICITY; META ANALYSIS; NECROTIZING ENTEROCOLITIS; NEPHROTOXICITY; NONHUMAN; OLIGURIA; PAIN; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PULMONARY HYPERTENSION; REVIEW; REYE SYNDROME; SLEEP; SLEEP PATTERN; SMALL INTESTINE PERFORATION; SPONTANEOUS ABORTION; THERMOREGULATION; THROMBOSIS;

EID: 0038199778     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200305060-00004     Document Type: Review

References (214)

1. Crofford LJ. Prostaglandin biology. Gastroenterol Clin North Am 2001 Dec; 30 (4): 863-76
2. Smith WL. Prostanoid biosynthesis and mechanisms of action. Am J Physiol 1992 Aug 1; 263 (2 Pt 2): F181-91
3. Dubois RN, Abramson SB, Crofford L, et al. Cyclooxygenase in biology and disease. FASEB J 1998 Sep; 12 (12): 1063-73
4. Warner TD, Giuliano F, Vojnovic I, et al. Nonsteroid drug selectivities for cyclooxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA 1999 Jun; 96: 7563-8
5. Kurumbail RG, Stevens AM, Gierse JK, et al. Structural basis for selective inhibition of cyclooxygenase-2 by antiinflammatory agents. Nature 1996 Dec; 384 (6610): 644-8
6. Crofford LJ. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol 1997 Jul 1, 9S
7. Olson DM, Mijovic JE, Zaragoza DB, et al. Prostaglandin endoperoxide H symhase type 1 and type 2 messenger ribonucleic acid in human fetal tissues throughout gestation and in the newborn infant. Am J Obstet Gynecol 2001 Jan: 184 (2): 169-74
8. Morham SG, Langenbach R, Loftin CD, et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1995 Nov 3; 83 (3): 473-82
9. Dinchuk JE, Car BD, Focht RJ, et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 1995 Nov 23; 378 (6555): 406-9
10. Schmedtje Jr JF, Ji YS, Liu WL, et al. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem 1997 Jan 3; 272 (1): 601-8
11. Ristimaki A, Garfinkel S, Wessendorf J, et al. Induction of cyclooxygenase-2 by interleukin 1 alpha: evidence for post-transscriptional regulation. J Biol Chem 1994 Apr 22; 269 (16): 11769-75
12. McAdam BF, Catella-Lawson F, Mardini IA, et al. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA 1999 Jan 5; 96 (1): 272-7
13. Portanova JP, Zhang Y, Anderson GD, et al. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med 1996 Sep 1; 184 (3): 883-91
14. Vanegas H, Schaible HG. Prostaglandins and cyclooxygenases in the spinal cord. Prog Neurobiol 2001 Jul 1; 64 (4): 327-63
15. Simpson JM. Infant stress and sleep deprivation as an aetiological basis for the sudden infant death syndrome. Early Hum Dev 2001 Feb; 61 (1): 1-43
16. Hayaishi O, Urade Y. Prostaglandin D2 in sleep-wake regulation: recent progress and perspectives. Neuroscientist 2002 Feb; 8 (1): 12-5
17. Mizoguchi A, Eguchi N, Kimura K, et al. Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep. Proc Natl Acad Sci USA 2001 Sep 25; 98 (20): 11674-9
18. Pinzar E, Kanaoka Y, Inui T, et al. Prostaglandin D synthase gene is involved in the regulation of non-rapid eye movement sleep. Proc Natl Acad Sci USA 2000 Apr 25; 97 (9): 4903-7
19. Erode RN, Harmon RJ, Metcalfe D, et al. Stress and neonatal sleep. Psychosom Med 1971 Dec; 33 (6): 491-7
20. Murphy PJ, Badia P, Myers BL, et al. Nonstemidal anti-inflammatory drugs affect normal sleep patterns in humans. Physiol Behav 1994 Jun; 55 (6): 1063-6
21. Murphy PJ, Myers BL, Badia P. Nonsteroidal antiinflammatory drugs alter body temperature and suppress melatonin in humans. Physiol Behav 1996; 59 (1): 133-9
22. Yaksh TL, Hua XY, Kalcheva I, et al. The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proc Natl Acad Sci USA 1999 July; 96: 7680-6
23. Buvanendran A, Kroin JS, Hemmati H, et al. Potentiation of morphine antinociception by L-745,337, a cyclooxygenase-2 (COX-2) inhibitor, in a model of postoperative pain: a dose response study [abstract S-204]. International Anesthesia Research Society 76th Clinical and Scientific Congress; 2002 Mar 16-20; San Diego (CA). Anesth Analg 2002 Feb; 94 (2 Suppl.): S204
24. Tolman EL, Fuller BL, Marinan BA, et al. Tissue selectivity and variability of effect of acetaminophen on arachidonic acid metabolism. Prostaglandins Leukot Med 1983; 12: 347-56
25. Flower RJ, Vane JR. Inhibition of prostaglandin synthetase in brain explains the antipyretic activity of acetaminophen. Nature 1972; 240: 410-1
26. Piletta P, Porchet HC, Dayer P. Central analgesic effect of acetaminophen but not of aspirin. Clin Pharmacol Ther 1991 Apr; 49 (4): 350-4
27. Bjorkman R, Hallman KM, Hedner J, et al. Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P. Pain 1994; 57: 259-64
28. Chemtob S, Beharry K, Barna T, et al. Differences in the effects in the newborn piglet of various nonsteroidal antiinflammatory drugs on cerebral blood flow but not on cerebrovascular prostaglandins. Pediatr Res 1991; 30 (1): 106-11
29. Aranda IV, Beharry K, Sasyniuk B, et al. The role of prostanoids in neonatal cerebral blood flow autoregulation. J Lipid Medial 1993; 6 (1-3): 493-501
30. Iadecola C, Niwa K, Nogawa S, et al. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci USA 2001 Jan 30; 98 (3): 1294-9
31. Govoni S, Masoero E, Favalli L, et al. The cyclooxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat. Neurosci Lett 2001 May 4; 303 (2): 91-4
32. Lapchak PA, Araunjo DM, Song D, et al. Neuroprotection by the selective cyclooxygenase-2 inhibitor SC-236 results in improvements in behavioral deficits induced by reversible spinal cord ischemia. Stroke 2001 May; 32 (5): 1220-5
33. Sugimoto K, Iadecola C. Delayed effect of administration of COX-2 inhibitor in mice with acute cerebral ischemia. Brain Res 2003 Jan; 960 (1-2): 273-6
34. Fowlie PW, Davis PG. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants (Cochrane Review). Available in The Cochrane Library [databse on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 3. Oxford: Update Software, 2002: CD000174
35. Yang T, Endo Y, Huang YG, et al. Renin expression in COX-2 knockout mice on normal or low salt diets. Am J Physiol Renal Physiol 2000 Nov; 279 (5): F819-25
36. Cheng HF, Wang JL, Zhang MZ, et al. Genetic deletion of COX-2 prevents increased renin expression in response to ACE inhibition. Am J Physiol Renal Physiol 2001 Mar; 280 (3): F449-56
37. Norwood VF, Morham SG, Smithies O. Posmatal development and progression of renal dysplasia in cyclooxygenase-2 null mice. Kidney Int 2000 Dec; 58 (6): 2291-300
38. Kammerl MC, Nusing RM, Schweda F, et al. Low sodium and furosemide induced stimulation of the renin system in man is mediated by cyclooxygenase 2. Clin Pharmacol Ther 2001 Nov; 70 (5): 465-74
39. Whelton A, Maurath CJ, Verburg KM, et al. Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor. Am J Ther 2000; 7: 151-2
40. Koehne PS, Bein G, Alexi-Meskishivili V, et al. Patent ductus arteriosus in very low birthweight infants: complications of pharmacological and surgical treatment. J Perinat Med 2001; 29: 327-34
41. Kang NS, Yoo KH, Cheon H, et al. Indomethacin treatment decreases renal blood flow velocity in human neonates. Biol Neonate 1999; 76: 261-5
42. Martinez FE, Reno C, Trevenen CL, et al. Age dependent changes in the regulation of cyclooxygenases in the gastrointestinal tract after gram negative endotoxemia. J Pediatr Gastroenterol Nutr 2001 Aug; 33 (2): 165-70
43. Pilbeam CC, Fall PM, Alander CB, et al. Differential effects of nonsteroidal antiinflammatory drugs on constitutive and inducible prostaglandin G/H synthase in cultured bone cells. J Bone Miner Res 1997; 12: 1198-203
44. Ho ML, Chang JK, Chuang LY, et al. Effects of nonsteroidal anti-inflammatory drugs and prostaglandins on osteoblastic functions. Biochem Pharmacol 1999 Sep; 58 (6): 983-90
45. Nollet J, Hahnekamp K, Van Aken H, et al. Clinically relevant acetylsalicylic acid concentrations inhibit GQ protein function [abstract S-310]. International Anesthesia Research Society 76th Clinical and Scientific Congress: 2002 Mar 16-20; San Diego (CA). Anesth Analg 2002 Feb: 94 (2 Suppl.): S310
46. Northover BJ. Indomethacin: a calcium antagonist. Gen Pharmacol 1977; 8 (5-6): 293-6
47. Schaff SM, Ingram RH. Influence of abdominal pressure and sympathetic vasoconstriction on the cardiovascular response to positive end-expiratory pressure. Am Rev Respir Dis 1977; 116 (4): 661-70
48. Pickard JD, Rose JE, Shaw M, et al. The effect of sodium salicylate on cerebral blood flow and metabolism. Br J Pharmacol 1980; 68: 407-11
49. Brooks PM, Day RO. Nonsteroidal antiinflammatory drugs: differences and similarities. N Engl J Med 1991 Jun 13; 324 (24): 1716-23
50. Riendeau D, Charleson S, Cromlish W, et al. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal antiinflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. Can J Physiol Pharmacol 1997 Sep; 75 (9): 1088-95
51. Autret E, Dutertre JP, Breteau M, et al. Pharmacokinetics of paracetamol in the neonate and infant after administration of propacetamol chlorhydrate. Dev Pharmacol Ther 1993 Jan 1; 20 (3-4): 129-34
52. Van Lingen RA, Deinum HT, Quak CM, et al: Multiple dose pharmacokinetics of rectally administered acetaminophen in term infants. Clin Pharmacol Ther 1999 Nov 1; 66 (5): 509-15
53. Anderson BJ, Woollard GA, Holford NH. A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children. Br J Clin Pharmacol 2000 Aug 1; 50 (2): 125-34
54. Van Lingen RA, Deinum JT, Quak JM, et al. Pharmacokinetics and metabolism of rectally administered paracetamol in preterm neonates. Arch Dis Child Fetal Neonatal Ed 1999 Jan 1; 80 (1): 59-63F
55. Hopkins CS, Underhill S, Booker PD. Pharmacokinetics of paracetamol after cardiac surgery. Arch Dis Child 1990 Sep 1; 65 (9): 971-6
56. Hansen TG, O'Brien K, Morton NS, et al. Plasma paracetamol concentrations and pharmacokinetics following rectal administration in neonates and young infants. Acta Anaesthesiol Scand 1999 Sep 1; 43 (8): 855-9
57. Anderson BJ, Holford NHG, Woollard GA, et al. Perioperative pharmacodyamics of acetaminophen analgesia in children. Anesthesiology 1999 Feb; 90 (2): 411-21
58. Aranda JV, Varvarigou A, Beharry K, et al. Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant. Acta Paediatr 1997; 86: 289-93
59. Olkkola KT, Maunuksela EL, Korpela R. Pharmacokinetics of postoperative intravenous indomethacin in children. Pharmacol Toxicol 1989 Aug 1; 65 (2): 157-60
60. Thalji AA, Carr I, Yeh TF, et al: Pharmacokinetics of intravenously administered indomethacin in premature infants. J Pediatr 1980; 97: 995-1000
61. Yaffe SJ, Friedman WF, Rogers D, et al. The disposition of indomethacin in preterm babies. J Pediatr 1980 Dec: 97 (6): 1001-6
62. Olkkola KT, Maunuksela EL. The pharmacokinetics of postoperative intravenous ketorolac tromethamine in children. Br J Clin Pharmacol 1991 Feb 1; 31 (2): 182-4
63. Ito K, Niida Y, Sato J, et al. Pharmacokinetics of mefenamic acid in preterm infants with patent ductus arteriosus. Acta Paediatr Jpn 1994 Aug 1; 36 (4): 387-91
64. Wiest DB, Pinson JB, Gal PS, et al. Population pharmacokineties of intravenous indomethacin in neonates with symptomatic patent ductus arteriosus. Clin Pharmacol Ther 1991 May 1; 49 (5): 550-7
65. Brash AR, Hiekey DE, Graham TP, et al. Pharmacokinetics of indomethacin in the neonate: relation of plasma indomethacin levels to response of the ductus arteriosus. N Engl J Med 1981 Jul 9: 305 (2): 67-72
66. Van den Anker JN. Pharmacokinetics and renal function in preterm infants. Acta Paediatr 1996 Dec; 85 (12): 1393-9
67. Van den Anker JN, Schoemaker RC, Hop WC, et al. Ceftazidime pharmacokinetics in preterm infants: effects of renal function and gestational age. Clin Pharmacol Ther 1995 Dec 1; 58 (6): 650-9
68. Van den Anker JN, Hop WC, Schoemaker RC, et al. Ceftazidime pharmacokinetics in preterm infants: effect of postnatal age and postnatal exposure to indomethacin. Br J Clin Pharrnacol 1995 Nov 1; 40 (5): 439-43
69. Gal P, Ransom JL, Weaver RL, et al. Indomethacin pharmacokinetics in neonates: the value of volume of distribution as a marker of permanent patent ductus arteriosus closure. Ther Drug Monit 1991 Jan 1: 13 (1): 42-5
70. Dumas de la Roque E, Fayon M, Babre F, et al. Minimal effective dose of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Biol Neonate 2002; 81 (2): 91-4
71. Ment LR, Oh W, Ehrenkranz RA, et al: Low dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 1994: 93 (4): 543-50
72. Anderson BJ. What we don't know about paracetamol in children. Paediatr Anaesth 1998 Jan 1; 8 (6): 451-60
73. Arendt-Nielsen L, Nielsen JC, Bjerring P. Double blind, placebo controlled comparison of paracetamol and paracetamol plus codeine: a quantitative evaluation by laser induced pain. Eur J Clin Pharmacol 1991 Jan: 40 (3): 241-7
74. Nielsen JC, Bjerring P, Arendt-Nielsen L, et al. Analgesic efficacy of immediate and sustained release paracetamol and plasma concentration of paracetamol: double blind, placebo controlled evaluation using painful laser stimulation. Eur J Clin Pharmacol 1992 Jan: 42 (3): 261-4
75. Peterson RG, Rumack BH. Pharmacokinetics of acetaminophen in children. Pediatrics 1978 Nov 1; 62 (5 Pt 2 Suppl.): 877-9S
76. Miller RP, Roberts RJ, Fischer LJ. Acetaminophen elimination kinetics in neonates, children, and adults. Clin Pharmacol Ther 1976 Mar 1: 19 (3): 284-94
77. Levy G, Khanna NN, Soda DM, et al. Pharmacokinetics of acetaminophen in the human neonate: formation of acetaminophen glucuronide and sulfate in relation to plasma bilirubin concentration and D-glucaric acid excretion. Pediatrics 1975 Jun 1; 55 (6): 818-25
78. Anderson BJ, Woolard GA, Holford NH. Pharmacokinetics of rectal paracetamol after major surgery in children. Paediatr Anaesth 1995 Jan; 5 (4): 237-42
79. Anderson BJ, Monteleone J, Holford NH. Variability of concentrations after rectal paracetamol [letter]. Paediatr Anaesth 1998 Jan 1; 8 (3): 274
80. Birmingham PK, Tobin MJ, Henthorn TK, et al. Twenty-four-hour pharmacokinetics of rectal acetaminophen in children. Anesthesiology 1997 Aug: 87 (2): 244-52
81. Birmingham PK, Tobin MJ, Fisher DM, et al. Initial and subsequent dosing of rectal acetaminophen in children. Anesthesiology 2001 Mar; 94 (3): 385-9
82. Bannwarth B, Netter P, Lapicque F, et al. Plasma and cerebrospinal fluid concentrations of paracetamol after a single intravenous dose of propacetamol. Br J Clin Pharmacol 1992 Jul 1; 34 (1): 79-81
83. Anderson BJ, Holford NH, Woollard GA. Paracetamol plasma and cerebrospinal fluid pharmacokinetics in children. Br J Clin Pharmacol 1998 Sep 1; 46 (3): 237-43
84. Anderson BJ, van Lingen RA, Hansen TG, et al. Acetaminophen developmental pharmacokinetics in premature neonates and infants: a pooled population analysis. Anesthesiology 2002 Jun' 96 (6): 1336-45
85. Kauffman RE, Nelson MV. Effect of age on ibuprofen pharmacokinetics and antipyretic response. J Pediatr 1992 Dec 1; 121 (6): 969-73
86. Adams SS, Bresloff P, Mason CG. Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (-)-isomer. J Pharm Pharmacol 1976 Mar; 28 (3): 256-7
87. Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of a patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi hospital. J Med Assoc Thai 2002 Nov; 85 Suppl. 4: S1252-8
88. Lago P, Bethol T, Salvadori S, et al. Safety and efficacy of ibuprofen vs indomethacin in preterm infants treated for patent ductus arteriosus: a randomized controlled trial. Eur J Pediatr 2002 Apr; 161 (4): 202-7
89. Sato J, Kudo N, Owada E, et al. Urinary excretion of mefenamic acid and its metabolites including their esterglucuronides in preterm infants undergoing mefenamic acid therapy. Biol Pharm Bull 1997 Apr 1: 20 (4): 443-5
90. Sakhalkar VS, Merchant RH. Therapy of symptomatic patent ductus arteriosus in preterms using mefenamic acid and indomethacin. Indian Pediatr 1992 Mar: 29 (3): 313-8
91. Burd RS, Tobias JD. The use of ketorolac for postoperative pain management in infants undergoing abdominal surgical procedures. South Med J 2002 Mar; 95 (3): 331-3
92. Korpela R, Olkkola KT. Pharmacokinetics of intravenous diclofenac sodium in children. Eur J Clin Pharmacol 1990 Jan 1; 38 (3): 293-5
93. Sylaidis P, O'Neill TJ. Diclofenac analgesia following cleft palate surgery. Cleft Palate Craniofac J 1998 Nov; 35 (6): 544-55
94. Maroof M, Jafri F, Khan RM, et al. Transdermal ketoprofen provides effective pain relief in postoperative period [abstract S-222], International Anesthesia Research Society 76th Clinical and Scientific Congress; 2002 Mar 16-20; San Diego (CA). Anesth Analg 2002 Feb: 94 (2 Suppl.): S222
95. Arana A, Morton NS, Hansen TG. Treatment with paracetamol in infants. Acta Anaesthesiol Scand 2001 Jan: 45 (1): 20-9
96. Hammerman C, Kaplan M, Patent ductus arteriosus in the premature neonate: current concepts in pharmacological management. Paediatr Drugs 1999; 1 (2): 81-92
97. Hammerman C, Kaplan M. Comparative tolerability of pharmacological treatments for patent ductus arteriosus. Drug Safety 2001 Jan; 24 (7): 537-51
98. Knight DB. The treatment of patent ductus arteriosus in preterm infants: a review and overview of randomized trials. Semin Neonatol 2001; 6: 63-73
99. Fowlie PW. Prophylactic indomethacin: systematic review and recta-analysis. Arch Dis Child Fetal Neonatal Ed 1996 Mar; 74 (2): F81-7
100. Schmidt B. Trial of indomethacin prophylaxis in preterm infants (TIPP). National Institute of Child Health and Human Development [online]. Available from URL: http://clinicaltrials.gov/ct/[Accessed 2002 Feb 28]
101. Narayanan M, Cooper B, Weiss H, et al. Prophylactic indomethacim factors determining permanent ductus arteriosus closure. J Pediatr 2000 Mar; 136 (3): 330-7
102. Van Overmeire B, Van de Brock H, Van Laer P, et al. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr 2001 Feb; 138 (2): 205-11
103. Schmidt B, Davis P, Moddemann D, et al., on behalf of the Trial of Indomethacin Prophylaxis in Preterms investigators. Long term effects of indomethacin prophylaxis in extremely low birth weight infants. N Engl J Med 2001 Jun 28; 344 (26): 1966-72
104. Ment LR, Vohr B, Allan W, et al. Outcome of children in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics 2000 Mar; 105 (3): 485-91
105. Supapannachart S, Khowsathit P, Patchakapati B. Indomethacin prophylaxis for patent ductus arteriosus (PDA) in infants with a birthweight of less than 1250 grams. J Med Assoc Thai 1999 Nov: 82 Suppl. 1: S87-92
106. Varvarigou A, Bardin CL, Beharry K, et al. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 1996 Feb 21; 275 (7): 539-44
107. Dani C, Bertini G, Reali MF, et al. Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants. Acta Paediatr 2000 Nov 1; 89 (11): 1369-74
108. Gournay V, Savagner C, Thirieez G, et al. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 2002; 27: 1486-8
109. Van Overmeire B, Brus F, van Acker KJ, et al. Aspirin versus indomethacin treatment of patent ductus arteriosus in preterm infants with respiratory distress syndrome. Pediatr Res 1995 Dec; 38 (6): 886-91
110. Van Overmeire B, Smets K, Lecoutere D, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000 Sep 7; 343 (10): 674-81
111. SoRelle R. Ibuprofen as effective as indomethacin for patent ductus arteriosus. Circulation 2000 Jul 25; 102 (4): E9007-8
112. Ng PC, So KW, Fok TF, et al. Comparing sulindac with indomethacin for closure of ductus arteriosus in preterm infants. J Paediatr Child Health 1997 Aug; 33 (4): 324-8
113. Takahashi Y, Roman C, Chemtob S, et al. Cyclooxygenase-2 inhibitors constrict the fetal lamb ductus arteriosus both in vitro and in vivo. Am J Physiol Regul Integr Comp Physiol 2000 Jun; 278 (6): R1496-505
114. Baker MD, Bell LM. Unpredictability of serious bacterial illness in febrile infants from birth to 1 month of age. Arch Pediatr Adolesc Med 1999 May; 153 (5): 508-11
115. Jaskiewicz JA, McCarthy CA, Richardson AC, et al. Febrile infants at low risk for serious bacterial infection: an appraisal of the Rochester criteria and implications for management. Pediatrics 1994 Sep: 94 (3): 390-6
116. Autret E, Reboul-Marty J, Henry-Launois B, et al. Evaluation of ibuprofen versus aspirin and paracetamol on efficacy and comfort in children with fever. Eur J Clin Pharmacol 1997; 51 (5): 367-71
117. Wong A, Sibbald A, Ferrero F, et al. Antipyretic effects of dipyrone versus ibuprofen versus acetaminophen in children: results of a multinational randomized, modified double-blind study. Clin Pediatr 2001 Jun; 40 (6): 313-24
118. Stevens DL. Could nonsteroidat antiinflammatory drugs enhance the progression of bacterial infections to toxic shock syndrome. Clin Infect Dis 1995 Oct; 21 (4): 977-80
119. Anand KJ, Hickey PR. Pain and its effects in the human neonate and fetus. N Engl J Med 1987 Nov 19; 317 (21): 1321-9
120. Franck LS, Gregory GA. Clinical evaluation and treatment of infant pain in the neonatal intensive care unit. In: Schechter NL, Berde CB, Yaster M, editors. Pain in infants, children, and adolescents. Baltimore (MD): Williams and Wilkins, 1993: 519-36
121. Canadian Paediatric Society. Prevention and management of pain and stress in the neonate. Pediatrics 2000 Feb; 105 (2): 454-61
122. Stevens B, Gibbins S, Franck LS. Treatment of pain in the neonatal intensive care unit. Pediatr Clin North Am 2000 Jun; 47 (3): 633-50
123. Collier J, editor. Treating moderate and severe pain in infants. Drug Ther Bull 1994 Mar 17; 32 (3): 21-4
124. Johnston CC, Collinge JM, Henderson SJ, et al. A cross-sectional survey of pain and pharmacological analgesia in Canadian neonatal intensive care units. Clin J Pain 1997 Dec 1; 13 (4): 308-12
125. Rumack BH. Aspirin versus acetaminophen: a comparative view. Pediatrics 1978 Nov 1; 62 (5 Pt 2 Suppl.): 943-6
126. Baer GA, Rorarius MG, Kolehmainen S, et al. The effect of paracetamol or diclofenac administered before operation on postoperative pain and behaviour after adenoidectomy in small children. Anaesthesia 1992 Dec 1; 47 (12): 1078-80
127. Van Lingen RA, Quak CM, Deinum HT, et al. Effects of rectally administered paracetamol on infants delivered by vacuum extraction. Eur J Obstet Gynecol Reprod Biol 2001 Jan 1; 94 (1): 73-8
128. Bremerich DH, Neidhart G, Heimann K, et al. Prophylactically administered rectal acetaminopben does not reduce postoperative opioid requirements in infants and small children undergoing elective cleft palate repair. Anesth Analg 2001 Apr: 92 (4): 907-12
129. Howard CR, Howard FM, Weitzman ML. Acetaminophen analgesia in neonatal circumcision: the effect on pain. Pediatrics 1994; 93: 641-6
130. Shah V, Taddio A, Ohlsson A. Randomised controlled trial of paracetamol for heel prick pain in neonates. Arch Dis Child Fetal Neonatal Ed 1998 Nov 1; 79 (3): 209-11F
131. Gaudreault P, Guay J, Nicol O, et al. Pharmacokinetics and clinical efficacy of intrarectal solution of acetaminophen. Can J Anaesth 1988; 35 (2): 149-52
132. McGaw T, Raborn W, Grace M. Analgesics in pediatric dental surgery: relative efficacy of aluminum ibuprofen suspension and acetaminophen elixir. ASDC J Dent Child 1987 Mar-Apr; 54 (2): 106-9
133. Rusy LM, Houck CS, Sullivan LJ, et al. A double blind evaluation of ketorolac tromethamine versus acetaminophen in pediatric tonsillectomy: analgesia and bleeding. Anesth Analg 1995; 80: 226-9
134. Vetter TR, Heiner EJ. Intravenous ketorolac as an adjuvant to pediatric patient controlled analgesia with morphine. J Clin Anesth 1994 Mar-Apr; 6 (2): 110-3
135. Maunuksela EL, Kokki H, Bullingham RE. Comparison of intravenous ketorolac with morphine for postoperative pain in children. Clin Pharmacol Ther 1992 Oct 1; 52 (4): 436-43
136. Watcha MF, Jones MB, Lagueruela RG, et al. Comparison of ketorolac and morphine as adjuvants during pediatric surgery. Anesthesiology 1992; 76: 368-72
137. Gupta A, Cheng J, Wang S, et al. Analgesic efficacy of ketorolac and morphine in neonatal rats. Pharmacol Biochem Behav 2001 Apr; 68 (4): 635-40
138. Sims C, Johnson CM, Bergesio R, et al. Rectal indomethacin for analgesia after appendectomy in children. Anaesth Intensive Care 1994 Jun; 22 (3): 272-5
139. Maunuksela EL, Olkkola KT, Korpela R. Does prophylactic intravenous infusion of indomethacin improve the management of postoperative pain in children. Can J Anaesth 1988 Mar 1; 35 (2): 123-7
140. Maunuksela EL, Olkkola KT, Korpela R. Intravenous indomethacin as postoperative analgesic in children: acute effects on blood pressure, heart rate, body temperature and bleeding. Ann Clin Res 1987 Jan 1; 19 (5): 359-63
141. Mourani CC, Sanjad SA, Akatcherian CY. Bartter syndrome in a neonate: early treatment with indomethacin. Pediatr Nephrol 2000 Feb 1; 14 (2): 143-5
142. Nusing RM, Reinalter SC, Peters M, et al. Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide. Clin Pharmacol Ther 2001 Oct 1; 70 (4): 384-90
143. Glibetic M, Samlalsingh-Parker J, Raykova V, et al. Group B streptococci and inducible nitric oxide synthase: modulation by nuclear factor kappa B and ibuprofen. Semin Perinatol 2001 Apr; 25 (2): 65-9
144. Raju NV, Bharadwaj RA, Thomas R, et al. Ibuprofen use to reduce the incidence and severity of bronchopulmonary dysplasia: a pilot study. J Perinatol 2000 Jan-Feb; 20 (1): 13-6
145. Nandgaonkar BN, Rotschild T, Yu K, et al. Indomethacin improves oxygen induced retinopathy in the mouse. Pediatr Res 1999 Aug; 46 (2): 184-8
146. Lindsley CB. Uses of nonsteroidal anti-inflammatory drugs in pediatrics. Am J Dis Child 1993 Feb; 147 (2): 229-36
147. Litalien C, Jacqz-Aigrain E. Risks and benefits of nonsteroidal antiinflammatory drugs in children. Paediatr Drugs 2001; 3 (11): 817-58
148. Ostensen M, Ostensen H. Safety of nonsteroidal antiinflammatory drugs in pregnant patients with rheumatic disease. J Rheumatol 1996 Jun 1; 23 (6): 1045-9
149. Van Marter LJ, Leviton A, Allred EN, et al. Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy. Pediatrics 1996 May; 97 (5): 658-63
150. Alano MA, Ngougmna E, Ostrea Jr EM, et al. Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn. Pediatrics 2001 Mar; 107 (3): 519-23
151. Nielsen GL, Sorenson HT, Larsen H, et al. Risk of adverse birth outcome and miscarriage in pregnant users of nonsteroidal antiinflammatory drugs: population based observational study and case control study. BMJ 2001; 322: 266-70
152. Talati AJ, Salim MA, Korones SB. Persistent pulmonary hypertension after maternal naproxen ingestion in a term newborn: a case report. Am J Perinatol 2000 Jan 1; 17 (2): 69-71
153. Zenker M, Klinge J, Kruger C, et al. Severe pulmonary hypertension in a neonate caused by premature closure of the ductus arteriosus following maternal treatment with diclofenac: a case report. J Perinat Med 1998 Jan 1; 26 (3): 231-4
154. Lauterburg BH, Vaishnav Y, Stillwell WG, et al. The effects of age and glutathione depletion on hepatic glutathione turnover in vivo determined by acetaminophen probe analysis. J Pharmacol Exp Ther 1980 Apr 1; 213 (1): 54-8
155. Isbister GK, Bucens IK, Whyte IM. Paracetamol overdose in a preterm neonate. Arch Dis Child Fetal Neonatal Ed 2001 Jul 1; 85 (1): 70-2F
156. Rumack BH, Peterson RG. Acetaminophen overdose: incidence, diagnosis, and management in 416 patients. Pediatrics 1978 Nov 1; 62 (5 Suppl Pt 2): 898-903S
157. Anderson B, Anderson M, Hastie B. Paracetamol prescribing habits in a children's hospital. NZ Med J 1996 Oct 11: 109 (1031): 376-8
158. Webster PA, Roberts DW, Benson RW, et al. Acetaminophen toxicity in children: diagnostic confirmation using a specific antigen biomarker. J Clin Pharmacol 1996 May 1; 36 (5): 397-402
159. Gerson A, Abbasi S, Johnson A, et al. Safety and efficacy of long-term tocolysis with indomethacin. Am J Perinatol 1990 Jan 1; 7 (1): 71-4
160. Vanhaesebrouck P, Thiery M, Leroy JG, et al. Oligohydramnios, renal insufficiency, and ileal perforation in preterm infants after intrauterine exposure to indomethacin. J Pediatr 1988 Oct 1; 113 (4): 738-43
161. Kaplan BS, Restaino I, Raval DS, et al. Renal failure in the neonale associated with in utero exposure to nonsteroidal antiinflammatory agents. Pediatr Nephrol 1994; 8: 700-4
162. Simeoni U, Messer J, Weisburd P, et al. Neonatal renal dysfunction and intrauterine exposure to prostaglandin synthesis inhibitors. Eur J Pediatr 1989 Jan 1; 148 (4): 371-3
163. van der Heijden AJ, Provoost AP, Nauta J, et al. Renal functional impairment in preterm neonates related to intrauterine indomethacin exposure. Pediatr Res 1988 Nov 1; 24 (5): 644-8
164. Betkerur MV, Yeh TF, Miller K, et al. Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus. Pediatrics 1981; 68: 99-102
165. Ojala R, Ala-Houhala M, Ahonen S, et al. Renal follow up of premature infants with and without perinatal indomethacin exposure. Arch Dis Child Fetal Neonatal Ed 2001 Jan; 84 (1): F28-33
166. Kuo CY. Treatment of patent ductus arteriosus with lose dose indomethacin in very low birth weight neonates with impairment of renal function: report of three cases. J Perinat Med 1996; 24 (6): 657-60
167. Wurtzel D. Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function. Obstet Gynecol 1990 Oct 1; 76 (4): 689-92
168. Baenziger O, Waldvogel K, Ghelfi D, et al. Can dopamine prevent the renal side effects of indomethacin: a prospective randomized clinical study. Klin Padiatr 1999; 211 (6): 438-41
169. Brion LP, Campbell DE. Furosemide in indomethacin treated infants: systematic review and meta-analysis. Pediatr Nephrol 1999 Apr; 13 (3): 212-8
170. Gouyon JB, Chouchane M, Francoise M. Renal effects of prolonged indomethacin therapy in premature infants. Arch Pediatr 1994 Oct 1; 1 (10): 894-7
171. Narayanan M, Schlueter M, Clyman RI. Incidence and outcome of a 10-fold indomethacin overdose in premature infants. J Pediatr 1999 Jul; 135 (1): 105-7
172. Mosca F, Bray M, Lattanzio M, et al. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 1997; 131 (4): 549-54
173. Patel J, Roberts I, Azzopardi D, et al. Randomized double blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 2000; 47: 36-42
174. Malcolm DD, Segar JL, Robillard JE, et al. Indomethacin compromises hemodynamics during positive pressure ventilation, independently of prostanoids. J Appl Physiol 1993 Apr: 74 (4): 1672-8
175. Trevisanuto D, Zaninotto M, Lachin M, et al. Effect of patent ductus arteriosus and indomethacin treatment on serum cardiac troponin T levels in preterm infants with respiratory distress syndrome. Eur J Pediatr 2000 Apr; 159 (4): 273-6
176. Pezzati M, Vangi V, Biagiotti R, et al. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 1999 Dec; 135 (6): 733-8
177. Seri I, Abbasi S, Wood DC, et al. Regional hemodynamic effects of dopamine in the indomethacin-treated preterm infant. J Perinatol 2002; 22:
178. Shorter NA, Liu JY, Mooney DP, et al. Indomethacin associated bowel perforations: a study of possible risk factors. J Pediatr Surg 1999 Mar 1; 34 (3): 442-4
179. Fujii AM, Brown E, Mirochnick M, et al. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus. J Perinatol 2002 Oct-Nov; 22 (7): 535-40
180. Hosono S, Ohno T, Kimoto H, et al. Reduction in blood glucose values following indomethacin therapy for patent ductus arteriosus. Pediatr Int 1999 Oct 1; 41 (5): 525-8
181. Grosfeld JL, Chaet M, Molinari F, et al. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann Surg 1996 Sep; 224 (3): 350-7
182. Ojala R, Ikonen S, Tammela O. Perinatal indomethacin treatment and neonatal complications in preterm infants. Eur J Pediatr 2000 Mar; 159 (3): 153-5
183. Yaseen H, al Umram K, Ali H, et al. Effects of early indomethacin administration on oxygenation and surfactant requirement in low birth weight infants. J Trop Pediatr 1997 Feb 1; 43 (1): 42-6
184. Simon LS, COX-2 inhibitors: are they nonsteroidal antiinflammatory drugs with a better safety profile. Gastroenterol Clin North Am 2001 Dec; 30 (4): 1011-25
185. Komers R, Anderson S, Epstein M. Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors. Am J Kidney Dis 2001 Dec: 38 (6): 1145-57
186. Perazella MA, Eras J. Are selective COX-2 inhibitors nephrotoxic. Am J Kidney Dis 2000 May; 35 (5): 937-40
187. Crofford LJ, Oates JC, McCune WJ, et al. Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors: a report of four cases. Arthritis Rheum 2000 Aug; 43: 1891-6
188. Jackson LM, Hawkey CJ. COX-2 selective nonsteroidal anti-inflammatory drugs: do they really offer any advantages. Drugs 2000 Jun; 59 (6): 1207-16
189. Cuzzolin L, Del Cere M, Fanos V. NSAID-induced nephrotoxicity from the fetus to the child. Drug Saf 2001 Jan; 24 (1): 9-18
190. Bombardier C, for the VIGOR Study Group. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000; 343: 1520-8
191. Matheson AJ, Figgitt DP, Rofecoxib: a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis. Drugs 2001; 61 (6): 833-65
192. Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal antiinflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study: a randomized controlled trial. JAMA 2000; 284: 1247-55
193. Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001 Aug; 286 (8): 954-9
194. Hennan JK, Huang J, Barrett TD, et al. Effects of cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries. Circulation 2001 Aug 14; 104 (7): 820-5
195. Catella-Lawson F, Crofford LJ. Cyclooxygenase inhibition and thrombogenicity. Am J Med 2001 Feb 19; 110 (3A Suppl.): 28-32S
196. Langenbach R, Morham SG, Tiano HF, et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid induced inflammation and indomethacin induced gastric ulceration. Cell 1995 Nov 3; 83:483-92
197. Komhoff M, Wang JL, Cheng HF, et al. Cyclooxygenase 2 selective inhibitors impair glomerulogenesis and renal cortical development. Kidney Int 2000 Feb; 57 (2): 414-22
198. Harris RC. Interactions between COX-2 and the renin-angiotensin system in the kidney. Acta Physiol Scand 2003 Apr; 177 (4): 423-7
199. Wang JL, Cheng HF, Shappell S, et al. A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats. Kidney Int 2000 Jun; 57 (6): 2334-42
200. Sanchez PL, Salgado LM, Ferreri NR, et al. Effect of cyclooxygenase-2 inhibition on renal function after renal ablation. Hypertension 1999 Oct; 34 (4 Pt 2): 848-53
201. Lesko SM, Mitchell AA. Renal function after short term ibuprofen use in infants and children. Pediatrics 1997; 100 (6): 954-7
202. Speziale MV, Allen RG, Henderson CR. Effects of ibuprofen and indomethacin on the regional circulation in newborn piglets. Biol Neonate 1999 Oct; 76 (4): 242-52
203. Chamaa NS, Mosig D, Drukker A, et al. The renal hemodynamic effects of ibuprofen in the newborn rabbit. Pediatr Res 2000; 48: 600-5
204. Buck ML, Grebe TA, Bond GR. Toxic reaction to salicylate in a newborn infant: similarities to neonatal sepsis. J Pediatr 1993 Jun; 122 (6): 955-8
205. Martinez-Frias ML, Rodriguez-Pinilla E, Prieto L. Prenatal exposure to salicylates and gastroschisis: a case control study. Teratology 1997 Oct; 56 (4): 241-3
206. Sasidharan CK, Kutty PM, Ajithkumar, et al. Fetal intracranial hemorrhage due to antenatal low dose aspirin intake. Indian J Pediatr 2001 Nov; 68 (11): 1071-2
207. Dasari R, Narang A, Vasishta K, et al. Effect of maternal low dose aspirin on neonatal platelet function. Indian Pediatr 1998 Jun; 35 (6): 507-11
208. Samaik AP, Reye's syndrome: hold the obituary. Crit Care Med 1999 Aug; 27 (8): 1674-6
209. Lianas B, Cavert MH, Apere H, et al. Adverse effects of ketoprofen after intrauterine exposure: value of plasma determination. Arch Pediatr 1996 Mar 1; 3 (3): 248-53
210. Bannwarth B, Lagrange F, Pehourcq F, et al. (S)-ketoprofen accumulation in premature neonates with renal failure who were exposed to the racemate during pregnancy. Br J Clin Pharmacol 1999 Apr; 47 (4): 459-60
211. Brouwers JR, de Smet PA. Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs. Clin Pharmacokinet 1994 Dec; 27 (6): 462-85
212. de Wildt SN, Kearns GL, Hop WC, et al. Pharmacokinetics and metabolism of intravenous midazolam in preterm infants. Clin Pharmacol Ther 2001; 7: 525-31
213. Cooper-Peel C, Brodersen R, Robertson A. Does ibuprofen affect bilirubinalbumin binding in newborn infant serum. Pharmacol Toxicol 1996 Dec 1; 79 (6): 297-9
214. Jain KK. Evaluation of intravenous parecoxib for the relief of acute post surgical pain. Expert Opin Investig Drugs 2000 Nov; 9 (11): 2717-23